
1-Fluoro-3-(fluoromethyl)benzene | CAS:2267-30-3
1-Fluoro-3-(fluoromethyl)benzene
- 名称:1-氟-3-(氟甲基)苯 | 1-Fluoro-3-(fluoromethyl)benzene
- CAS号:2267-30-3
- 别名:m-Fluorobenzyl fluoride
- 分子式:C7H6F2
- 分子量:128.12
- EINESC号:
产品描述
物理化学性质
沸点 | 135.6±15.0 ºC (760 Tor |
---|---|
闪点 | 25.9±8.3 ºC, 计算值* |
密度 | 1.110±0.06 g/cm3 (20 º |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Apoptosis and impaired axonal regeneration of sensory neurons after nerve crush in diabetic rats.S Kogawa et al.Neuroreport, 11(4), 663-667 (2000-04-11)
Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase.M Nishikawa et al.Cellular signalling, 4(4), 453-463 (1992-07-01)
Activation of extracellular signal-regulated protein kinase in dorsal horn neurons in the rat neuropathic intermittent claudication model.Yi Liu et al.Pain, 109(1-2), 64-72 (2004-04-15)
A synthetic analog of prostaglandin E(1) prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate-treated rats.Feng Gao et al.Life sciences, 71(9), 1091-1099 (2002-06-29)
OP-1206, a prostaglandin E1 derivative, attenuates the thermal hyperesthesia induced by constriction injury to the sciatic nerve in the rat.T Yamamoto et al.Anesthesia and analgesia, 80(3), 515-520 (1995-03-01)
Reappraisal of OP-1206, a prostaglandin E1 derivative in combination with low-flow oxygen inhalation therapy in chronic lung disease.T Ishizaki et al.Japanese journal of medicine, 28(1), 34-40 (1989-01-01)
Oral prostaglandin E1 as a therapeutic modality for leg ulcers in Behçet's disease.A Takeuchi et al.International journal of clinical pharmacology research, 7(4), 283-289 (1987-01-01)
Potent inhibition of leukotriene (LT) B4 release from human polymorphonuclear leukocytes (PMN) by the PGE1-analogue OP-1206.P Ney et al.Biomedica biochimica acta, 47(10-11), S186-S189 (1988-01-01)
Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.T Kanayama et al.The Journal of pharmacology and experimental therapeutics, 255(3), 1210-1217 (1990-12-01)
A prostaglandin E1 analog, OP-1206, alleviates 5-fluorouracil-induced injury of rat small intestine.K Hirata et al.Research communications in molecular pathology and pharmacology, 104(3), 243-251 (2000-03-31)
Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.M Sonobe et al.Diabetes, 40(6), 726-730 (1991-06-01)
A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.H Yasuda et al.Metabolism: clinical and experimental, 41(7), 778-782 (1992-07-01)
Effects of orally administered OP-1206 alpha-CD with loxoprofen-Na on walking dysfunction in the rat neuropathic intermittent claudication model.Katsuhiko Nakai et al.Prostaglandins, leukotrienes, and essential fatty acids, 69(4), 269-273 (2003-08-09)
The effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model.Katsuhiko Nakai et al.Anesthesia and analgesia, 94(6), 1537-1541 (2002-05-29)
Effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol.Katsuhiko Nakai et al.Prostaglandins & other lipid mediators, 71(3-4), 253-263 (2003-10-02)
[A new oral prostaglandin E1 derivative (OP 1206) compared with intravenous PGE1: assessment of the effect on macro- and microcirculation].P Scheffler et al.VASA. Supplementum, 32, 386-391 (1991-01-01)
[Intracellular actions of antiplatelet drugs which affect cyclic AMP metabolism in platelets--their effects on Ca2+ mobilization and protein phosphorylation in human platelets].M Nishikawa et al.Rinsho byori. The Japanese journal of clinical pathology, Suppl 86, 54-61 (1990-07-01)
Metabolic effect of PGE1 analogue 01206.alpha CD on nerve Na(+)-K(+)-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: possible role of cAMP in diabetic neuropathy.H Yasuda et al.Prostaglandins, 47(5), 367-378 (1994-05-01)
Effect of a synthetic analog of prostaglandin E1 on the intestinal mucosa of methotrexate-treated rats.F Gao et al.Anticancer research, 21(3B), 1913-1917 (2001-08-11)
Stimulation of intestinal epithelial restitution by prostaglandin E(1) analogue.Kohji Hirata et al.Cancer chemotherapy and pharmacology, 51(3), 216-220 (2003-03-26)
Potent inhibition of superoxide anion generation by PGE1 and the PGE1 analogue OP-1206 in human PMN's--unrelated to its antiplatelet PGI2-like activity.K Schrör et al.VASA. Supplementum, 17, 11-16 (1987-01-01)
Analysis of localization of adult T-cell leukemia-derived factor in the transient ischemic rat retina after treatment with OP-1206 alpha-CD, a prostaglandin E1 analogue.M Yamamoto et al.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 45(1), 63-70 (1997-01-01)
Effects of OP-1206 (prostaglandin E1) on nerve-conduction velocity in the dog cauda equina subjected to acute experimental compression.S Konno et al.Journal of spinal disorders, 9(2), 103-106 (1996-04-01)
Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.T Saji et al.Japanese heart journal, 32(5), 735-740 (1991-09-01)
Correlation between methotrexate-induced intestinal damage and decrease in polyamine content.Feng Gao et al.Life sciences, 72(6), 669-676 (2002-12-07)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!